ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can donor t cells beat a tough virus after transplant? new trial aims to find out.
Disease control Recruiting nowThis early-stage study tests whether infusing virus-fighting T cells from a donor can help stem cell transplant patients overcome a stubborn adenovirus infection. About 20 participants will receive the experimental cell therapy, and researchers will monitor side effects and wheth…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: EARLY_PHASE1 • Sponsor: Mari Dallas • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Ancient heat therapy could ease Life-Threatening transplant complication
Disease control Recruiting nowThis study tests whether moxibustion, a traditional therapy that burns herbs near the skin, can help people with severe graft-versus-host disease (GVHD) after a stem cell transplant. GVHD happens when donor cells attack the patient's body, causing pain and diarrhea. The trial wil…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
Could adding a targeted drug to transplant prep boost survival in older blood cancer patients?
Disease control Recruiting nowThis phase 3 trial tests whether adding the targeted drug venetoclax to standard chemotherapy (fludarabine + melphalan) before a donor stem cell transplant improves outcomes for adults over 50 with acute myeloid leukemia or myelodysplastic syndrome. The study aims to reduce relap…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 11, 2026 12:11 UTC
-
Food bags for transplant patients: a recipe for better recovery?
Disease control Recruiting nowThis study looks at whether providing free bags of groceries to patients undergoing stem cell transplants or CAR-T cell therapy can help improve their nutrition and treatment results. Many patients face high medical costs that make it hard to afford enough food, which can hurt th…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 09, 2026 12:06 UTC
-
Tailored transplant doses aim to boost blood cancer survival
Disease control Recruiting nowThis study tests a personalized approach to stem cell transplants for people with blood cancers like leukemia and lymphoma. The treatment uses different doses of chemotherapy and radiation based on each patient's risk level. The goal is to improve how long patients live without t…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE2 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 03, 2026 12:06 UTC